{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:53:38Z","timestamp":1767837218170,"version":"3.49.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 48-year-old man presented with upper abdominal discomfort for 10\u2009days. Abdominal contrast-enhanced CT showed multiple abnormal enhanced masses in liver, suggesting a probability of malignancies. The patient was then enrolled in a clinical trial of comparison of <jats:sup>18<\/jats:sup>F-FDG and <jats:sup>18<\/jats:sup>F-FAPI PET\/CT in hepatic lesions. Compared with <jats:sup>18<\/jats:sup>F-FDG PET\/CT, <jats:sup>18<\/jats:sup>F-FAPI PET\/CT showed higher tracer uptake, more lesions in liver. Meanwhile, peripheral blood eosinophils increased remarkably. The hepatic lesions were highly suspected as eosinophilic liver infiltration. Finally, pathologic analysis confirmed the diagnosis of eosinophilic liver infiltration.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005675","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:18Z","timestamp":1737676818000},"page":"e483-e485","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["18F-FDG PET\/CT Versus 18F-FAPI PET\/CT in Eosinophilic Liver Infiltration"],"prefix":"10.1097","volume":"50","author":[{"given":"Shuyi","family":"Li","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiucen","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Province, People' s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haipeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rusen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"bib1-20250630","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/ajh.25617","article-title":"World Health Organization\u2013defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management","volume":"94","author":"Shomali","year":"2019","journal-title":"Am J Hematol"},{"key":"bib2-20250630","first-page":"123","article-title":"Idiopathic hypereosinophilic syndrome presenting with liver mass: report of two cases: idiopathic hypereosinophilic syndrome and liver mass","volume":"11","author":"Shatery","year":"2011","journal-title":"Hepat Mon"},{"key":"bib3-20250630","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s40644-023-00626-y","article-title":"Head-to-head comparison of 18F-FAPI and 18F-FDG PET\/CT in staging and therapeutic management of hepatocellular carcinoma","volume":"23","author":"Zhang","year":"2023","journal-title":"Cancer Imaging"},{"key":"bib4-20250630","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00259-020-05070-9","article-title":"Comparison of PET imaging of activated fibroblasts and 18F-FDG for diagnosis of primary hepatic tumours: a prospective pilot study","volume":"48","author":"Shi","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib5-20250630","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1097\/RLU.0000000000004073","article-title":"Tumor imaging with 68Ga-DOTA-FAPI-04 PET\/CT: comparison with 18F-FDG PET\/CT in 22 different cancer types","volume":"47","author":"\u00c7ermik","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib6-20250630","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1097\/RLU.0000000000005148","article-title":"Intense 18 F-FAPI uptake in small recurrent lesions of combined hepatocellular-cholangiocarcinoma negative on 18 F-FDG PET\/CT","volume":"49","author":"Liang","year":"2024","journal-title":"Clin Nucl Med"},{"key":"bib7-20250630","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13550-024-01145-y","article-title":"Role of 18F-FAPI-04 in staging and therapeutic management of intrahepatic cholangiocarcinoma: prospective comparison with 18F-FDG PET\/CT","volume":"14","author":"Liang","year":"2024","journal-title":"EJNMMI Res"},{"key":"bib8-20250630","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00259-022-06022-1","article-title":"18F-FAPI PET\/CT in the evaluation of focal liver lesions with 18F-FDG non-avidity","volume":"50","author":"Zhang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib9-20250630","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.1097\/RLU.0000000000003015","article-title":"68Ga-FAPI PET\/CT in assessment of liver nodules in a cirrhotic patient","volume":"45","author":"Zhao","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib10-20250630","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1097\/RLU.0000000000004801","article-title":"Increased 18F-FAPI uptake in radiation-induced liver injury","volume":"48","author":"Zhang","year":"2023","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T16:01:29Z","timestamp":1751299289000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005675","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"2024-10-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}